2. Academic Validation
  3. Metabolic Changes in Early-Stage Non-Small Cell Lung Cancer Patients after Surgical Resection

Metabolic Changes in Early-Stage Non-Small Cell Lung Cancer Patients after Surgical Resection

  • Cancers (Basel). 2021 Jun 16;13(12):3012. doi: 10.3390/cancers13123012.
Naseer Ahmed 1 2,  Biniam Kidane 1 3 4,  Le Wang 5 6,  Zoann Nugent 5,  Nataliya Moldovan 2,  April McElrea 6,  Shiva Shariati-Ievari 6,  Gefei Qing 7,  Lawrence Tan 4,  Gordon Buduhan 4,  Sadeesh K Srinathan 4,  Michel Aliani 6 8
Affiliations

Affiliations

  • 1 Research Institute in Oncology and Hematology, CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada.
  • 2 Department of Radiology, Section of Radiation Oncology, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3T 2N2, Canada.
  • 3 Department of Community Health Sciences, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0W3, Canada.
  • 4 Department of Surgery, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3A 1R9, Canada.
  • 5 CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada.
  • 6 St. Boniface Hospital Albrechtsen Research Centre, Winnipeg, MB R2H 2A6, Canada.
  • 7 Department of Pathology, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 3P5, Canada.
  • 8 Department of Food and Human Nutritional Sciences, University of Manitoba, Winnipeg, MB R3T 2N2, Canada.
PMID: 34208545 DOI: 10.3390/cancers13123012
Abstract

Metabolic alterations in malignant cells play a vital role in tumor initiation, proliferation, and metastasis. Biofluids from patients with non-small cell lung Cancer (NSCLC) harbor metabolic biomarkers with potential clinical applications. In this study, we assessed the changes in the metabolic profile of patients with early-stage NSCLC using mass spectrometry and nuclear magnetic resonance spectroscopy before and after surgical resection. A single cohort of 35 patients provided a total of 29 and 32 pairs of urine and serum samples, respectively, pre-and post-surgery. We identified a profile of 48 metabolites that were significantly different pre- and post-surgery: 17 in urine and 31 in serum. A higher proportion of metabolites were upregulated than downregulated post-surgery (p < 0.01); however, the median fold change (FC) was higher for downregulated than upregulated metabolites (p < 0.05). Purines/pyrimidines and proteins had a larger dysregulation than Other classes of metabolites (p < 0.05 for each class). Several of the dysregulated metabolites have been previously associated with Cancer, including leucyl proline, asymmetric dimethylarginine, isopentenyladenine, fumaric acid (all downregulated post-surgery), as well as N6-methyladenosine and several deoxycholic acid moieties, which were upregulated post-surgery. This study establishes metabolomic analysis of biofluids as a path to non-invasive diagnostics, screening, and monitoring in NSCLC.

Keywords

biofluids; lung cancer; metabolomics; surgical resection.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z